AtriCure (ATRC) Proxy filing summary

Executive summary

• The 2026 Annual Meeting will be held virtually on May 18, 2026, with shareholders able to vote electronically and submit questions online.

• Shareholders of record as of March 26, 2026, are entitled to vote on key proposals, including director elections, auditor ratification, amendments to equity plans, and executive compensation.

• The Board recommends voting in favor of all proposals, including the election of nine directors, amendments to stock incentive and employee stock purchase plans, and the advisory say-on-pay vote.

Voting matters and shareholder proposals

• Proposals include electing nine directors for one-year terms, ratifying Deloitte & Touche LLP as auditor for 2026, amending the 2023 Stock Incentive Plan to add 1.5 million shares, amending the 2018 Employee Stock Purchase Plan to add 750,000 shares, and an advisory vote on executive compensation.

• Shareholders may submit proposals or director nominations for the 2027 meeting between November 9 and December 7, 2026.

Board of directors and corporate governance

• The Board consists of nine members, eight of whom are independent; the CEO is not independent.

• Board committees include Audit, Compensation, Compliance/Quality/Risk, Nominating/Corporate Governance, and Strategy, each with defined responsibilities and independent membership.

• The Board emphasizes diversity, with 56% female directors, and was recognized for DEI initiatives.

• Directors are encouraged to attend meetings, and all attended at least 75% of meetings in 2025.